Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Labelling
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 11 of 11 items.
Teva-Atenolol; Product label image incorrect
RecallHealth product recall | 2022-11-21
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17